MEETINGS - "Medical Devices - The commercialisation story" (Ireland) April 2005:
This article was originally published in Clinica
BioConnect Ireland, a biosciences networking organisation, is hosting the conference "Medical Devices - The commercialisation story" in Dublin on April 28. The three presentations, to be followed by panel discussion and networking, will discuss IP, investment and "future trends in medical devices from a corporate perspective". Details of the event and free registration at: www.biotechnologyireland.com
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.